News

If the EU Commission agrees, this will be the first time that a coronavirus vaccine based on neither mRNA nor vector technology will be marketed in the EU Read more

Recommendation does not apply to all children in the age group. Target group are girls and boys with pre-existing conditions Read more

The European Medicines Agency endorses the vector vaccine not only for the booster vaccination at least two months after the first vaccination. It may now also be used as a booster after vaccination with mRNA vaccines. The STIKO sees it differently thus far Read more

The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency advocates administering booster shots using Moderna's COVID-19 vaccine Read more

Extension of approval for third COVID-19 vaccination with Comirnaty Read more

The FDA in the US grants emergency approval for a single booster dose, but only for people 65 and over and for other risk groups. One side effect seems to occur more frequently after the third vaccination than after the second vaccination Read more

The dangerous anti-PF4 antibodies, which can lead to cerebral vein thrombosis after vaccination with Vaxzevria®, disappear from the body after some time and are not regenerated by the second vaccination Read more

Experts recommend vaccination starting in the second trimester of pregnancy. Breastfeeding people should receive two doses of an mRNA vaccine 3 to 6 weeks (Comirnaty) or 4 to 6 weeks (Spikevax) apart Read more

Both BioNTech/Pfizer and Moderna plan to apply for approval of their Comirnaty® and Spikevax® vaccines for children shortly Read more

The European Commission must still give its approval Read more

Comirnaty and Spikevax: Warning notices now also in the EU Read more

Moderna vaccine now called Spikevax Read more

EMA warning for Vaxzevria, FDA warning for J&J vaccine Read more

At least 85% of those ages 12-59 and 90% of those 60 and over should be fully vaccinated in a timely manner Read more

In light of the approval of the vaccine for 12- to 15-year-olds, the STIKO makes a joint recommendation for children and adolescents Read more

EMA allows storage for 31 days at 2 - 8° Celsius Read more

People who received a different vaccine for the first vaccination than for the second vaccination were more likely to report vaccine reactions than people who received the same vaccine for both vaccinations. Read more

A recent study published in the Lancet shows that BioNTech/Pfizer's vaccine not only protects against severe COVID-19 but also protects against asymptomatic infections. Read more

According to EMA, the thromboses described in the US are similar to those that occurred after administration of AstraZeneca's Vaxzevria vaccine in Europe. Read more

The risk of cerebral sinus and cerebral vein thrombosis after vaccination with AstraZeneca's Vaxzevria vaccine is apparently nine times higher than after vaccination with the mRNA vaccines. Read more

Vaccinations are important. But what if the person getting vaccinated speaks little or no German? The solution: aidminutes.vaccination Read more